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In the present study, we used the fetal organ culture (FTOC) technique in order to study a
putative effect of epidermal growth factor (EGF) on the thymus ontogeny. Functional EGF
receptors and more recently the EGF molecule itself, respectively, on the membrane of epithelial
components of thymic stroma and on a few thymocytes in adult thymus, had been reported in the
literature. We could observe a dose-dependent decrease in cellularity and a progressive retention
of thymocytes in the double-negative (CD4-/CD8-) stage of differentiation when exogenous
EGF was added. Epidermal growth factor interfered with both fetal stroma growth and
thymocyte development at a precise moment, that is, in the passage from double-negative to the
double-positive (CD4+/CD8+) stage. After a 7-day FTOC in the presence of EGF, most cells
recovered were Thy-l.2+, c-kit+, TSA1 -/int, CD3-, and one of CD44high/CD25int, CD44-/
CD25int, or CD44-/CD25-. Some developed into y6TCR cells with a mature (CD3+)
phenotype, but not into cq3TCR thymocytes. It seems that EGF addition makes the cultures
"nonpermissible" for o43TCR thymocyte generation. We report here the presence of a high Mr
"EGF-like" molecule on the membrane of fetal thymocytes, which role in the observed effects
is under investigation. Further biochemical characterization of this molecule is still required,
because its presence was only evidenced on the basis of its antigenicity.
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INTRODUCTION
Thymus ontogeny is marked by a sequence of events
that lead the precursors derived from fetal liver or
bone marrow to a mature T-cell stage (Godfrey and
Zlotnik, 1993; Anderson and Perlmutter, 1995). In the
mouse, colonization starts at 10 to 11 days of fetal life
(Palacios and Samaridis, 1991), being succeeded by
growth and differentiation of both thymocyte pre-
cursors and stromal cells, whose specialization
depends on a mutual signaling, in a symbiotic
relationship (Ritter and Boyd, 1993; Hollinder et al.,
1995). This cross-talk is mediated by soluble cyto-
kines and hormones, direct contact through membrane
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molecules, and extracellular matrix deposition (Boyd
et al., 1993; Savino et al., 1993), and is still poorly
understood at least for the initial, pre-T-cell receptor
expression stages. Fetal thymus organ cultures
(FTOCs) allow these stages to be investigated,
because after 7 to 12 days in vitro, starting with 13- to
15-day thymuses, the colonized intact organs develop
mimicking almost entirely the in vivo situation up to
delivery (Ceredig, 1988), which occurs around 20
days of fetal life. We used this technique to inves-
tigate a possible role for epidermal growth factor
(EGF) in the thymus, because functional EGF recep-
tors had been demonstrated on the membrane of the
epithelial components of thymic stroma (Le et al.,
1991), and a few cells in the adult thymus were shown
by immunohistochemistry to express the EGF
molecule itself (Screpanti et al., 1995).
EGF and its receptor are ubiquitously distributed in
mammalian tissues (Carpenter, 1993). Curiously, they
had been reported to be missing in mature hemato-
poietic cell types (Carpenter, 1993), until the synthe-
sis and exportation of a member of the family,
heparin-binding EGF, was shown in human peripheral
blood T lymphocytes (Blotnick et al., 1994). Soluble
EGF is present in many body fluids and produced in
large quantities by platelets and submaxillary glands
in the adult male mouse, physiologically displaying a
circadian variation in submaxillary glands, but not in
plasma (Krieger et al., 1976), where its levels reach a
concentration as high as 152 ng/mL after an
adrenergic stimulus (Byyni et al., 1974; Grau et al.,
1994). The small peptide, with a Mr of approximately
6000, results from the proteolytic cleavage of a larger
membrane complex (Mr 74,000), which consists of
two EGF peptides bearing a carboxyl-terminal argi-
nine residue linked to two molecules of EGF-binding
protein, an arginin esteropeptidase (Carpenter and
Cohen, 1979). Its precursor, prepro-EGF, has an Mr
of approximately 130,000 (Gray et al., 1983), and in
some tissues such as kidneys, it is not cleaved but
expressed as a transmembrane integral protein (Rall et
al., 1985), for which a putative receptor function has
been suggested (Carpenter, 1993).
We describe here a blockade of thymocyte growth
and differentiation on the addition of exogenous EGF
to FTOC, and the presence of a high Mr "EGF-like"
molecule on the membrane of fetal thymocytes, which
persists in the adult thymus roughly up to the passage
to the double-positive CD4+/CD8 stage, suggesting
that the EGF system plays a pivotal role in thymus
ontogeny at least during these early stages of
differentiation.
RESULTS
Effects of Exogenous EGF Addition to Fetal
Thymuses In Vitro
When 14-day fetal thymuses were exposed to natural
murine EGF, a dose-dependent decrease in cellularity
and a retention of thymocytes in the double-negative
(DN; CD4-/CD8-) stage of differentiation could be
observed (Figure 1). Such effect depended on the
maintenance ofEGF throughout the 7 days of culture,
because growth and differentiation resumed when
EGF was subtracted on day 3 of culture, and stopped
when EGF was added on this day to control cultures
(Figure 2A). The most primitive cells colonizing fetal
thymus, however, seemed to survive even to 7 days of
culture in the presence of 100 ng/mL EGF, whose
subtraction allowed thymocytes to resume their
differentiation process (Figure 2B), although with a
lag phase longer than 1 week. Yet, fully developed
FTOC were not seen, with respect to percentages of
single-positive subsets, even for longer periods in the
absence of EGF.
As reported in the literature, fetal thymocytes can
only grow in vitro when the relationship between
them and the stromal-cell types is maintained in the
intact organ architecture (Watson et al., 1989). Lobe
submersion cultures (LSC), in which the organs are
cultured and submerged in medium, result in thymo-
cyte death unless IL-7 and/or IL-2 are added (Watson
et al., 1989). In this case, both cytokines restore
growth of the less differentiated thymocyte sub-
populations, but cannot restore differentiation up to
the double-positive (DP; CD4+/CD8+) stage (Watson
et al., 1989). In our experiments, the growth of
thymocytes in LSC in the presence of IL-2 plus IL-7
was unaffected by EGF (data not shown). The growthEGF MODULATES MURINE THYMUS ONTOGENY 171
of epithelial stromal elements over the substrate,
however, was profoundly impaired in the presence of
EGF (Figure 3). In the case of the EGF-driven
blockade of FTOC, even at a suboptimal dose (20 ng/
mL), neither normal growth nor differentiation of
thymocytes could be resumed by the addition of IL-2
plus IL-7, and again only the most immature subsets
were expanded (Figure 4A).
It was shown that DN thymocytes bear minute
quantities of membrane-bound CD3e, capable of
switching intracellular signals, and treatment with
anti-CD3E antibodies can lead thymocytes from
immunodeficient mice to advance in their way to
differentiation (Levelt et al., 1993a, 1993b; Jacobs et
al., 1994; Shinkai and Alt, 1994). We then tried to
overcome the blocking effects ofEGF by adding anti-
CD3E antibodies to FTOC. This procedure led part of
the immature DN thymocytes one step further, that is,
to the CD4’w/CD8 phenotype (Figure 4B), but not to
the DP stage.
The progression of immature thymocytes to the DP
stage was demonstrated to occur in short-term
suspension cultures involving cell division, but inde-
pendent of an intact stromal compartment, which in
fact negatively regulates this step (Takahama et al.,
1994). Fetal thymus lobes from 14-day-old fetuses
were cultured intact (FTOC) for 24 h, either in the
presence or absence of 100 ng/mL EGF. Suspensions
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FIGURE Dose-response of mnEGF on FTOC. Fourteen-day fetal thymic lobes were cultured intact as described in Materials and
Methods. Exogenous mnEGF (ng/mL) was added at the beginning of culture and cells were harvested 7 days later for cytofluorometric
analysis of CD4/CD8 expression. Values within each panel represent percentages, whereas mean cellularity per lobe is seen at the bottom
right. Each point represents a pool of eight lobes. Similar results were observed in two further experiments.172 C.S. FREITAS et al.
were made from both pools of lobes, and 5 105 cells
from each separate pool were seeded in 24-well plates
for 16 h in mL complete medium, either in the
presence or absence of 100 ng/mL EGF. After 16 h of
culture, the four suspensions (C/C: control FTOC plus
16 h without EGF; C/EGF: control FTOC plus 16 h
with EGF; EGF/C: EGF-FTOC plus 16 h without
EGF; and EGF/EGF: EGF-FTOC plus 16 h with
EGF) were double-stained with anti-CD4-PE and
anti-CDS-FITC antibodies and differentiation
assessed by cytofluorometric analysis. Results are
described in Figure 5, which depicts one representa-
tive experiment. Recovery ranged from 62% in C/C to
46% in EGF/EGF cells. The profiles of CD4/CD8
staining were closely similar among the pairs, but
whereas in the C/C and C/E suspension cultures,
around 20% of the survivers showed a DP phenotype,
in the EGF/C and EGF/EGF cultures, we could not
observe a similar transition to the DP phenotype,
suggesting that exogenous EGF acted in the first 24 h
of culture, in the intact organ, instead of directly in the
suspension cultures.
Taken together, these data argue against a general
toxic effect of exogenous EGF on thymocytes,
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FIGURE 2 EGF effects on FTOC depends on its maintenance in culture media. (A) (Control): FTOC in the absence of EGF for 7 days.
(+3): EGF (100 ng/mL) was added on the third day of culture, and cells were harvested on the seventh day. (-3): EGF was added at the
beginning of culture and subtracted on the third day, the cells being harvested on the seventh day. Values within each panel represent
percentages, and mean cellularity per lobe is seen at bottom right. Each point represents a pool of five lobes. Similar results were observed
in two further experiments. (B) (Control): FTOC in the absence of EGF for 7 days; (EGF): FTOC in the presence of EGF for 7 days. (-7
+ 10): EGF was added at the beginning of culture and subtracted at the seventh day, and the cultures were maintained for 10 additional days.
(-7 + 15): EGF was added at the beginning of culture and subtracted at the seventh day, and the cultures were maintained for 15 additional
days. Each point represents a pool of six lobes. Similar results were observed in two further experiments.EGF MODULATES MURINE THYMUS ONTOGENY 173
suggesting that EGF rather interferes with a precise
checking point in thymocyte development, affecting
both the stromal structure and the thymocyte subsets.
Surface Characteristics of Thymocytes Recovered
from a 7-day EGF-FTOC
and EGFint (Figure 7A), TSA1
-/int (a lymphostromal
molecule that was shown to regulate early thymocyte
development) (Randle et al., 1993) (Figure 7B), and
some develop into y6TCR thymocytes with a mature
phenotype (CD3/, not shown). In fact, it seems that
EGF addition makes the culture "nonpermissible" for
cffI’CR thymocyte generation (Figure 7C).
The cells recovered from 7-day EGF-FTOC (100 ng/
mL EGF) are Thy-l.2 (not shown), the majority
being distributed among CD3-/CD44high/CD25int,
CD3-/CD44-/CD25int, and CD3-/CD44-/CD25-
(Figure 6). Most are c-kit (as the most primitive cells
colonizing the thymus) (Godfrey and Zlotnik, 1993)
FIGURE 3 EGF blocks growth of epithelial cells in explanted
fetal thymus lobes. Fourteen-day aged fetal thymus lobes (five to
six per plate) were submerged in complete medium in the absence
(A) or presence (B) of 100 ng/mL EGF for 20 days. Cultures were
then fixed with methanol and immunostained with polyclonal rabbit
anti-pan-cytokeratin antiserum followed by FITC-conjugated goat
anti-rabbit IgG Abs (260 magnification). Similar results were
obtained in three further experiments.
Recognition of EGF-like Molecules on the Surface
of Immature Thymocytes
Cytofluorometric analysis of thymocyte suspensions
from 14-day fetuses (mostly DN), incubated with
rabbit polyclonal anti-EGF antiserum followed by
FITC-conjugated anti-rabbit IgG Abs, revealed posi-
tive staining, which was also present in the DN
subsets of young adult thymus and of control FTOC
thymocytes (Figure 8A). Curiously, a less bright
pattern of anti-EGF staining (logarithmic scale) was
observed for the DN thymocytes recovered from a
7-day EGF-FTOC (100 ng/mL EGF), compared to
fresh fetal thymocytes, and that did not seem to
accompany the reduction in cell size (linear scale)
(Figure 8B).
When fetal thymocyte suspensions from 14- and
16-day fetuses were submitted to SDS-PAGE, blotted
and revealed with anti-EGF rabbit antiserum followed
by PA conjugated anti-rabbit Abs, we could observe a
band with an approximate Mr of 120,000 (Figure 9)
which was not present in extracts from other fetal or
adult tissues (heart and liver), and could be only
observed in adult thymocyte extracts when as many as
107 cells were extracted for analysis (not shown).
When the same extracts were run under reducing
conditions (/3-mercaptoethanol in the sample buffer)
and the blot developed with the same antiserum, the
120,000-Mr band was not observed, nor was it
observed when the nonreducing electrophoresis was
blotted and developed with normal rabbit serum as
control (not shown).
The preceding data suggest that an EGF-like
immunoreactive molecule is present on the surface of
immature thymocytes and is possibly implicated in174 C.S. FREITAS et al.
the effects observed following exogenous EGF addi-
tion.
DISCUSSION
We report here a blockade of fetal thymocyte
development in vitro on the addition of exogenous
EGF to FTOC. The effect is dose-dependent and
requires the constant presence of EGF, a fact that
prevents the evaluation of the influence of this factor
on each cellular compartment separately, in lobe
reconstitution experiments using EGF-preincubated
cells, for example. It was apparent, however, that both
thymocyte and stromal compartments were affected,
possibly at their interaction, because in LSC, the
growth of the cytokeratin-positive cell subset was
blocked on EGF addition, whereas the growth of
immature thymocytes, which depends on IL-2 and/or
IL-7 addition and is rather independent of stromal
interaction (Watson et al., 1989), was not affected by
EGF (not shown).
With respect to the thymocyte compartment, a
blockade in differentiation seemed to occur in FTOC,
because the tentative reversal of EGF effects by the
addition of IL-2 and IL-7 to FTOC-EGF did in fact
expand the immature subset, but could not reverse the
retention imposed by this factor in the passage to the
DP stage (Figure 4A). Figure 5 reinforces this
conclusion, because this step was effectively blocked
by the action of EGF in the intact organ but not in the
thymocytes freed from stromal interactions, a fact
arguing against a general toxic effect. Even anti-CD3E
MoAb, used to lead the DN phenotype into DP in
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FIGURE 4 EGF-induced blockade of thymocyte differentiation in FTOC is not reverted by cytokines or anti-CD3e antibodies. EGF added
from the beginning at (A) 20 ng/mL and (B) 100 ng/mL; IL-2 at 20 U/mL, IL-7 at 20 ng/mL; and anti-CD3e antibodies at 25 g/mL final
concentration. Values within each panel represent percentages, and mean cellularity per lobe is seen at bottom right. Each point represents
a pool of (A) 5 and (B) 8 lobes. Similar results were observed in two further experiments.EGF MODULATES MURINE THYMUS ONTOGENY 175
immunodefficient mice (Levelt et al., 1993a, 1993b;
Jacobs et al., 1994; Shinkai and Alt, 1994), pushed
DN cells up to an intermediate stage, that is, CD4]w/
CD8+, but without overcoming the EGF-imposed
blockade in the transition to the DP phenotype (Figure
4B).
When we analyzed the surface phenotype of the
remaining FTOC-EGF immature cells compared to
that of fetal thymocytes, we found that an EGF-like
EGF-FTOC
EGF/C
i/i’F
6
CD8 ’
FIGURE 5 Cytofluorometric analysis of CD4/CD8 expression
after a 16-h suspension culture of immature thymocytes. Fetal
thymus lobes were first cultured intact in the absence (Contr)I-
FTOC) or presence (EGF-FTOC) of 100 ng/mL EGF for 24 h.
The lobes were smashed, suspensions incubated for h in complete
medium in order to exclude adherent cells. Aliquots were
immunostained for CD4/CD8, and the remaining cells were seeded
(5 105 in mL of complete medium) in 24-well plates and
incubated for 16 additional hours either in the absence or in the
presence of 100 ng/mL EGF before being harvested and evaluated
by flow cytometry. (C/C): 24-h Control-FTOC plus a 16-h
suspension culture without EGF. (C/EGF): 24-h Control-FTOC
plus a 16-h suspension culture containing EGF. (EGF/C): 24-h
EGF-FTOC plus a 16-h suspension culture without EGF. (EGF/
EGF): 24-h EGF-FTOC plus a 16-h suspension culture with EGF.
Values within each panel represent percentages from total living
cells. Similar results were observed in two further experiments.
immunoreactive molecule was present in the latter but
had its expression decreased in the former, whereas a
similar decrease could not be observed with other
surface molecules, such as c-kit (Figures 7 and 8).
This raised the hypothesis that "membrane-EGF" may
take part in the observed effects. The "EGF-bearing"
cells would either be aborted, the exogenous. EGF
acting as an inhibitor of a necessary interaction of the
membrane-immobilized molecule with EGF receptors
in neighboring cells, or prevented from expressing
this molecule (downregulation) due to the lack of this
interaction. This putative relationship was reinforced
because in adult young thymuses, the surface anti-
EGF staining remains present in the DN thymocyte
subset up to the transition to the DP stage (Figure 8).
Within this context, knowing that epithelial compo-
nents of young thymic stroma express EGF receptors
(Le et al., 1991; Screpanti et al., 1995), one may
assume that the "EGF system" takes part in the cross-
talk between immature thymocytes and these stromal
elements, not only during fetal life, but also in the
physiology of the thymus after birth. Although the
exogenous EGF-driven blockade of thymocyte
differentiation described here worked as a tool for
demonstrating a putative physiological event that still
remains to be further clarified, it should be mentioned
that the maximal EGF dose used (Figure 1) is still
below the plasma EGF levels reached in mice
subjected to an o-adrenergic stimulus (Byyni et al.,
1974; Grau et al., 1994), and therefore it remains
possible that under this circumstance an in vivo
blockade can also occur.
Surprisingly, the addition of exogenous EGF to
submerged fetal thymus cultures impaired the growth
of epithelial (cytokeratin-positive) cells from the
explanted organs over the substrate, instead of acting
as a growth factor, as has been reported for soluble
EGF added to thymic epithelial cells (Le et al., 1991).
It seemed puzzling that a growth factor inhibited
instead of enhancing the growth of its target cell,
unless its presence was in fact impairing a preexisting
signal that occurred physiologically. This apparently
occurs for stem-cell factor (SCF; c-kit ligand) (Miya-
zawa et al., 1995). In this case, a transmembrane
protein precursor generated a more persistent signal176 C.S. FREITAS et al.
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FIGURE 6 Surface characteristics of the thymocytes recovered after 7-day culture in the presence of 100 ng/mL EGF, compared to
Control-FTOC thymocytes and young adult mouse thymocytes. Triple staining consisted of anti-CD25 (IL-2R)-FITC MoAb, anti-CD44-
quantum red MoAb, and anti-CD3e biotin MoAb+ PE-conjugated streptavidin. Plots in R1, R2, R3, and R4 represent analysis of CD44/
CD25 patterns for regions from anti-CD3e histograms, in which R1 represents the first region at left (negative). Values within each panel
represent percentages from total living cells. Similar results were observed in two further experiments.EGF MODULATES MURINE THYMUS ONTOGENY 177
than the soluble one, which was transient due to
prompt internalization with the receptor. Biologically
active transmembrane precursors have also been
demonstrated for macrophage colony-stimulating fac-
tor, IL-1c and TGFo (a member of the EGF family
that shares with it the same receptor) (Massagu6,
1983; Kurt-Jones et al., 1985; Beuscher et al., 1987;
Brachman et al., 1989; Wong et al., 1989; Anklesaria
et al., 1990; Stein et al., 1990; Teixid6 et al., 1990). It
seems possible that in the fetal thymic micro-
environment, EGF acts similarly to SCF in bone
marrow, so that soluble EGF may actually "switch
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FIGURE 7 Surface characteristics of the thymocytes recovered after 7-day culture in the presence of 100 ng/mL EGF, compared to
Control-FTOC thymocytes, 14-day fetal thymocytes, and young adult mouse thymocytes. Double-stainings consisted of anti-c-kit-PE MoAb
rabbit anti-EGF antiserum followed by FITC-conjugated goat anti-rabbit IgG Abs, and anti-cq3 TCR-FITC MoAb anti-y6 TCR-biotin
MoAb followed by tricolor-conjugated streptavidin. Anti-TSA1-FITC MoAb single staining is plotted against size (FSC), and each point
represents a pool of six, eight, and six lobes, respectively.178 C.S. FREITAS et al.
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FIGURE 8 Cytofluorometric analysis of anti-CD4/CD8/EGF triple staining. Profiles from normal adult, 14-day fetal, Control-FTOC, and
EGF-FTOC (100 ng/mL EGF) thymocytes are shown. (A) Histograms represent anti-EGF profiles for each thymocyte subset defined by
CD4/CD8 analysis (contour plots). (B) Comparison of 14-day fetal thymocytes (black) and EGF-FTOC thymocytes (after a 7-day culture;
gray) in terms of intensity of anti-EGF staining (log scale) and size (linear scale). Each point represents a pool of 12 lobes.EGF MODULATES MURINE THYMUS ONTOGENY 179
off" the physiological task of a membrane-immobil-
ized "EGF-like" molecule.
It should be mentioned that exogenous TGFc (100
ng/mL; human recombinant; Gibco/BRL) did also
affect FTOC in a manner similar to that seen with
200
f 14 f 16
FIGURE 9 Presence of a high Mr, anti-EGF immunoreactive
molecule in fetal thymocytes. Western blot of 14-day aged (F14)
and 16-day aged (F16) fetal thymocytes. Extracts were made using
6 105 cells, which were solubilized and boiled in sample buffer
under nonreducing conditions, run on a 7.5% SDS-PAGE, blotted
onto nitrocellulose membranes, and developed with anti-EGF
antiserum followed by PA-conjugated goat anti-rabbit IgG Abs.
The position of the Mr standards (10
_3 is shown at left.
EGF (data not shown), as did tyrphostins (unpub-
lished results), specific blockers of EGF-receptor
tyrosine kinase activity (Levitzki and Gazit, 1995),
which suggests the intermediation of EGF receptors
in the mentioned blockade. Also, recombinant human
EGF (> 98% pure by HPLC; Gibco/BRL) was as
effective as, or even more effective than, natural
murine EGF (data not shown), showing that what we
observed was not caused by another substance present
in trace amounts as a contaminant.
Within this context, it should be emphasized that
although the epithelial growth was impaired in EGF-
LSC, other cell types such as fibroblasts grew
exuberantly over substrate (data not shown). One may
assume that an imbalance among the thymic micro-
environmental cell types was being imposed by EGF
addition, favoring fibroblast growth. A role for
mesenchimal cells besides epithelial ones in thymic
cross-talk has been demonstrated (Anderson et al.,
1993), However, the addition of another fibroblast
growth-inducing activity, namely, basic fibroblast
growth factor (Boehringer, Mannheim, Germany), did
not produce effects similar to those of EGF on FTOC
development (not shown). Because some CD3+/
Tb’TCR cells, but not cq3TCR cells, developed in
EGF-FTOC (Figure 7), it seems that this growth
factor made the thymic microenvironment "non-
permissible" for the development of o/3TCR line-
ages. As suggested by Farr et al. (1990), the
contribution of thymic environment to the differen-
tiation of these distinct lineages seems to be qualita-
tively different.
Lastly, one should mention that immobilized EGF-
like repeats are present in various extracellular matrix
proteins (Engel, 1989; Yamada, 1991), including
laminin and tenascin, which are constitutive compo-
nents of the thymic microenvironment (Savino et al.,
1993; Freitas et al., 1995) and have been shown to
play important roles in cellular development in other
systems (End et al., 1992; Schuppan and Rhl, 1994),
besides modulating T-cell functions (Shimizu et al.,
1990; Hemesath et al., 1994). Also adhesion mole-
cules, such as P-selectin, contain immobilized EGF-
like repeats, in this case responsible for leukocyte
binding to endothelium (Gibson et al., 1995). Thus,180 C.S. FREITAS et al.
for a better understanding of the role of the EGF
system in thymus physiology, immobilized EGF-like
repeats should be also evaluated.
MATERIALS AND METHODS
Animals
C57BL6/J mice from the animal facilities of the
National Cancer Institute of Rio de Janeiro were used.
Females were bred overnight, separated from males in
the morning (day 0), and maintained on a diet
supplemented with sunflower and corn seeds for 14
days. Pregnant females were killed by ether anes-
thesia, the uterus was excised, and fetuses were
harvested under sterile conditions, and washed in
HBSS (Sigma Co., St. Louis, MO).
Fetal Thymus Organ Cultures (FTOC) and
Lymphocyte Submersion Cultures
The fetal organ cultures were run as described in the
literature (Ceredig, 1988) with some modifications.
By using a watchmaker forceps, the thymuses were
excised into Petri dishes containing culture medium
(DMEM, with 2 g/L sodium bicarbonate, with
osmolarity adjusted to 310 mOsm with NaC1) and
further cleaned fro,m residual contaminating tissues
with the aid of a needle. Lobes were assembled (5 to
10 per dish) on a 0.22-/xm Millipore membrane
(previously boiled in a large volume of Milli-Q water)
sustained by a stainless steel grid inside of a delta
NUNC plate (Nunclon, Rosvilde, Denmark) contain-
ing 1.5 mL of culture medium with 10% FCS (defined
serum, Hyclone, Logan, UT), glutamine, nonessential
amino acids (Gibco/BRL; Life Technologies, Gai-
thersburg, MD), 60 mg/L penicillin and 100 mg/L
streptomycin. Complete medium was changed every 3
days, and after 7 to 12 days of culture, lobes were
harvested into a small volume of medium, smashed
under a glass coverslip, and thymocytes were har-
vested and counted, being either suspended in ice-
cold medium when processed for flow cytometry or
washed in HBSS and dissolved in sample buffer when
submitted to SDS-PAGE. For lymphocyte submersion
cultures (LSC), lobes were explanted to the plates in
the absence of the grid and membrane, being
submerged in complete medium, and lymphocytes
were harvested simply by flushing the medium at a
given time, and the stromal adherent components
were saline-washed and methanol-fixed for immuno-
histochemical analysis, as described in what follows.
Murine natural EGF (mnEGF; from mouse sub-
maxillary glands, a single band by Western blot using
anti-mouse EGF; E-4127 Sigma) was used. Other
cytokines used were human rIL-2, Hoffman-LaRoche
(kindly given by Dr. Richard Peck, Basel Institute for
Immunology), and murine rIL-7 (R&D Systems,
Minneapolis, MN).
Antibodies
Purified hamster anti-mouse CD3-e MoAb (no azide/
low endotoxin), clone 145-2Cll; biotin-conjugated
hamster anti-mouse CD3-e MoAb; PE-conjugated rat
anti-mouse CD117 (c-kit receptor) MoAb, clone 3C 1;
FITC-conjugated rat anti-mouse TSA1 MoAb, clone
MTS35, and PE-conjugated hamster anti-mouse
ySI’CR, clone GL3, were purchased from Pharmin-
gen (San Diego). Rabbit polyclonal anti-mouse EGF
antiserum; FITC-conjugated goat anti-rabbit IgG Ab;
alkaline phosphatase (PA)-conjugated goat anti-rabbit
IgG Ab; FITC-conjugated rat anti-mouse CD25 (IL-
2R) MoAb, clone AMT13, and quantum red-conju-
gated rat anti-mouse CD44 (Pgpl) MoAb, clone
IM7.8.1, were Sigma products. FITC-conjugated rat
anti-mouse Thy 1.2 MoAb, clone 30-H12; PE-
conjugated rat anti-mouse CD4 MoAb, clone GK1.5;
FITC-conjugated rat anti-mouse CD8 MoAb, clone
53-6.7, and PE-conjugated streptavidin were obtained
from Becton Dickinson (San Jose, CA). Tricolor-
conjugated streptavidin and biotin-conjugated ham-
ster anti-mouse TCRcq3 MoAb, clone H57-597, were
purchased from Caltag (San Francisco) and Gibco!
BRL, respectively.
Flow Cytometry
Cells in ice-cold medium or HBSS plus 2% FCS were
submitted to double or triple staining and then treatedEGF MODULATES MURINE THYMUS ONTOGENY 181
with propidium iodide at a final concentration of 2
g/mL in order to exclude the dead cells. Acquisition
was performed in a FACScan apparatus (Becton
Dickinson) equipped with a 15-mW air-cooled
488-nm argon-ion laser. Fluorescein green fluores-
cence and PE or PI orange fluorescence were
collected after 530- and 585-nm band-pass filters,
respectively. Appropriate electronic compensation
was applied between these fluorescence channels to
remove spectral overlap. Data acquisition was carried
out using the LYSYS II software program (BDIS) on
a HP9000/300 Hewlett-Packard computer. Twenty
thousand events were harvested from each sample.
Electrophoresis and Western Blots
Fetal thymocytes, adult thymocytes or other tissues
were dissolved and boiled in sample buffer and
analyzed by 7.5% acrylamide-bisacrylamide SDS-
PAGE, according to Laemmli and Favre (1973),
under nonreducing conditions. Proteins were trans-
ferred in Towbin’s buffer containing 0.1% SDS to
0.45-/xm nitrocellulose membranes, which were
blocked with 3% BSA in tris-buffered saline, and
developed with rabbit polyclonal anti-mouse EGF
antiserum, followed by PA-conjugated goat anti-
rabbit IgG Abs, and with the Sigma Fast BCIP/NBT
buffered substrate system (0.15 mg/mL 5-bromo-
4-chloro-3-indolyl phosphate; 0.30 mg/mL nitro blue
tetrazolium; 100 mM Tris; 5 mM MgCI2). Mr
standards were Rainbow Coloured Proteins (Amer-
sham, Buckinghamshire, UK).
Immunocytochemistry
Fourteen-day fetal thymus lobes were explanted and
cultured for 20 days submerged in complete medium
(half volume carefully changed every 3 days) inside
24-well culture plates. The plates were saline-washed,
methanol-fixed, and stained with rabbit anti-pan-
cytokeratin antiserum (Dako, Glostrup, Denmark),
followed by FITC-conjugated goat anti-rabbit IgG
Abs.
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